Visceral Fat Area and Serum Adiponectin Level Predict the Development of Metabolic Syndrome in a Community-Based Asymptomatic Population

337 asymptomatic adults without metabolic syndrome at baseline (aged 30-64 years, median age 56, 56.08% female) from the Seoul Metabolic Syndrome cohort. Excluded: previous history of angina pectoris, myocardial infarction, stroke, or any revascularization.

High visceral fat area (VFA) and low serum adiponectin level (Group 4: adiponectin < 12.55 ng/mL and VFA ≥ 58 cm2 for women; adiponectin < 7.34 ng/mL and VFA ≥ 84 cm2 for men)

Low visceral fat area (VFA) and high serum adiponectin level (Group 1: adiponectin ≥ 12.55 ng/mL and VFA < 58 cm2 for women; adiponectin ≥ 7.34 ng/mL and VFA < 84 cm2 for men)

1-year incidence rate of metabolic syndromecomposite